Physician profile
Chad Mathis
NPI 1467444927
$23,634.19
in general payments reported to CMS, 2019-2025
11 companies · $22K in 2025
The $22K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.33 · 2022: $14.47 · 2023: $1,089 · 2024: $940 · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Food and Beverage: $2,999 · Travel and Lodging: $2,019 · Education: $7.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,546.50 |
| Food and Beverage | $2,998.60 |
| Travel and Lodging | $2,019.33 |
| Education | $7.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $20,433.76 | 2024-2025 | Evenity, Prolia |
| Stryker Corporation | $1,159.10 | 2024-2025 | Blueprint Patient Specific Instrumentation, Reunion, Axsos |
| Linvatec Corporation | $925.85 | 2023 | Biobrace 23mm, Linvatec Shoulder Arthroscopy, Conmed Handheld Instruments |
| Smith+Nephew, INC. | $593.82 | 2023-2025 | Accu-Pass, Polarcup, Evos |
| Blue Surgical LLC | $156.92 | 2025 | |
| Radius Health, INC. | $108.11 | 2024 | Tymlos |
| Pfizer INC. | $88.30 | 2023-2025 | |
| Boston Scientific Corporation | $54.22 | 2022-2025 | Wavewriter Alpha Prime 16 |
| Eli Lilly and Company | $47.33 | 2019 | |
| Alexion Pharmaceuticals, INC. | $41.12 | 2024-2025 | Strensiq |
| Medtronic, INC. | $25.66 | 2024 | Symplicity G3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Mathis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.